Generics

Amneal has appointed Gustavo Pesquin as executive vice president, chief commercial officer of specialty, effective Sept. 6.

​​​​​​​Stimufend is indicated for the treatment of cancer patients undergoing chemotherapy to reduce the incidence of infection as manifested by febrile neutropenia.

Lannett anticipates launching biosimilar insulin glargine in the first half of 2024.

David Petrie is joining the board and Ian Scholes, deputy chair, will retire from the board at the end of September.

Generic Sprycel is indicated for adults with a certain type of chronic myeloid leukemia and generic Pristiq is used to treat depression.

Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis and corticosteroid and estrogen therapy.

Generic Compazine is used to treat the symptoms of psychosis and severe nausea or vomiting.

Generic BiCNU is used to treat certain types of brain tumors and blood cancers.